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Background:  The purpose of our study was to evaluate whether gender bias is prevalent in coronary revascularisation choices as recorded in a 
large European registry.
Methods:  We explored the EuroHeart survey on coronary revascularisation for evidence of gender differences in the decision to perform coronary 
artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) or no revascularisation in patients with angiographically documented 
coronary artery disease (≥50% stenosis) without prior revascularisation. We corrected for confounding by using a logistic regression analysis with a 
stepwise backwards elimination approach.
Results:  In 3939 patients (2959 men, 980 women), women were less likely than men to be treated with CABG (26.7 vs 21.7%, p<0.001). Adjusted 
for confounding co-morbidities and patient characteristics (Table 1), CABG rates in women <60 years were similar to CABG rates in men (OR 1.21, 
0.80-1.75), whereas women >60 years underwent CABG less frequently than men did (OR 0.60, 0.57-0.65).
Conclusion: Women >60 years were significantly less likely to be treated with CABG than men >60 years, indicating an age-dependent gender 
disparity in revascularisation choices.
Table 1. Unadjusted and adjusted logistic regression models with CABG as outcome (against PCI or no revascularisation) and gender and age as 
determinants. 
Model 1 Model 2 Model 3
OR 95%-CI OR 95%-CI OR 95%-CI
Constant 0.27 0.13 0.13
Male <60 years --- --- ---
Female <60 years 1.20 (0.83-1.64) 1.21 (0.82-1.79) 1.19 (0.80-1.75)
Male >60 years --- --- ---
Female >60 years 0.58 (0.55-0.61) 0.63 (0.59-0.68) 0.60 (0.57-0.65)
Chronic renal disease 0.44 (0.26-0.73) 0.45 (0.27-0.74)
≥3 vessel disease, n (%) 7.42 (6.19-8.88) 7.50 (6.28-8.95)
Left main disease, n (%) 3.50 (2.60-4.70) 3.47 (2.59-4.66)
Hypertension 0.86 (0.71-1.03) 0.86 (0.72-1.03)
Peripheral vascular disease 1.13 (0.86-1.47)
Cerebrovascular disease 1.06 (0.78-1.45)
Prior myocardial infarction 1.08 (0.90-1.30)
Smoking never 1.03 (0.92-1.14)
Hypercholesterolemia 0.92 (0.77-1.10)
Congestive heart failure 1.16 (0.94-1.43)
Chronic lung disease 1.04 (0.77-1.41)
Diabetes Mellitus 0.89 (0.72-1.09)
Body mass index ≥30 1.03 (0.83-1.28)
